Co-Authors
This is a "connection" page, showing publications co-authored by Alessio Mazzoni and Federico Lavorini.
Connection Strength
0.340
-
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent. J Clin Invest. 2020 09 01; 130(9):4694-4703.
Score: 0.225
-
Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab. PLoS Pathog. 2021 02; 17(2):e1009243.
Score: 0.058
-
Pulmonary vascular improvement in severe COVID-19 patients treated with tocilizumab. Immunol Lett. 2020 12; 228:122-128.
Score: 0.057